DELVE INTO AFRICAN WEALTH
DON'T MISS A BEAT
Subscribe now
Skip to content

South Africa’s Saltzman family sees $28.6 million gain from Dis-Chem shares

This increase highlights the family's position as one of South Africa’s wealthiest.

South Africa’s Saltzman family sees $28.6 million gain from Dis-Chem shares
Ivan Saltzman

Table of Contents


Key Points

  • Saltzman family stake in Dis-Chem rises to $476 million after shares gain 6.4% in just 22 days on the Johannesburg Stock Exchange.
  • Dis-Chem shares rise 6.4% since May 8, lifting the company’s market cap to over $1.6 billion and delivering solid gains to major investors.
  • Despite recent gains, Dis-Chem shares are down 6.57% in 2025, with a $100,000 investment declining to $93,430, reflecting lingering market pressures.

The Saltzman family—among South Africa’s wealthiest—has recorded a significant boost in the market value of their stake in Dis-Chem Pharmacies, following a sharp rise in the company’s share price on the Johannesburg Stock Exchange (JSE)

Saltzman family’s Dis-Chem stake hits $476 million

Lynette and Ivan Saltzman, the founders of Gauteng-based healthcare giant Dis-Chem, along with their family, own a 29.3 percent stake in the company—amounting to 252,066,319 shares.

In the past 22 days alone, the market value of the family’s stake has risen by R511.69 million ($28.63 million), bringing their total holding to $476 million. This increase highlights the family's position as one of South Africa’s wealthiest.

This recent gain follows an earlier rise in their stake’s value, which grew by $53.5 million between Apr. 4 and May 5. During that period, their holdings climbed from R7.08 billion ($387.44 million) to R9.17 billion ($515.9 million), highlighting the steady strength of their investment in Dis-Chem.

Dis-Chem shares surge nearly 6.4% in 22 days

Founded more than four decades ago, Dis-Chem has grown into one of South Africa’s leading names in retail healthcare. The company operates dispensaries, family clinics, wound care centers, and large self-medication hubs, cementing its role as a vital part of everyday healthcare for many South Africans.

In the past three weeks, Dis-Chem’s share price has climbed 6.4 percent, rising from R31.70 ($1.77) on May 8 to R33.73 ($1.89). This steady gain has lifted the company’s market capitalization to more than $1.6 billion—bringing welcome returns to its investors, especially the Saltzman family.

Thanks to the share price increase, the value of the Saltzmans’ 29.3-percent stake has grown by R511.7 million ($28.6 million), moving from R7.99 billion ($447 million) to R8.5 billion ($475.7 million).

Your money and your life

Although Dis-Chem’s shares have bounced back in recent weeks, they’re still down 6.57 percent for the year. An investment of $100,000 at the start of 2025 would now be worth $93,430—a drop of $6,570. That dip underscores the ongoing challenges the company faces, even as the stock shows signs of recovery.

The intelligence satisfies curiosity. The paid briefings satisfy strategy.

Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.

Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.

Executive ($25/mo): Daily newsletter + Deep-Dive Reports

Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings

Subscribe now

Latest